New Heart Failure Trials

Clinical trials focused on heart failure research, exploring new therapies and treatment strategies. Some of these trials aim to address unmet needs or build upon existing knowledge to improve heart failure management.

EMPEROR-Preserved: This trial investigated the use of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, in patients with heart failure and preserved ejection fraction (HFpEF). The study assessed the potential benefits of this drug in reducing heart failure hospitalizations and improving cardiovascular outcomes in this specific patient population.

GALACTIC-HF: This global trial evaluated the efficacy and safety of omecamtiv mecarbil, a novel cardiac myosin activator, in patients with heart failure and reduced ejection fraction (HFrEF). The study aimed to determine whether this new therapy could improve cardiac function and reduce heart failure-related events.

VICTORIA: This trial investigated the use of vericiguat, a soluble guanylate cyclase stimulator, in patients with worsening chronic heart failure. The study examined the drug's potential to reduce cardiovascular death and heart failure hospitalization rates.

These trials and others are crucial in advancing the understanding of heart failure and identifying new treatment options that could potentially benefit patients in the future. It's essential to consult the latest scientific literature or clinical trial registries for updates and results.

    Related Conference of New Heart Failure Trials

    August 08-09, 2024

    13th World Heart Congress

    London, UK
    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    September 19-20, 2024

    6th Annual Conference on Vascular Medicine

    London, UK
    September 19-20, 2024

    7th World Heart and Brain Conference

    London, UK
    October 17-18, 2024

    38th World Congress on Heart Diseases

    London, UK
    October 17-18, 2024

    3rd International Conference on Cardiology

    London, UK
    October 17-18, 2024

    8th Annual Heart Rhythm Conference

    Barcelona, Spain
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland
    December 10-11, 2024

    6th Euro Cardiology Congress

    Dubai, UAE
    December 26-27, 2024

    28th World Cardiology Conference

    Aix-en-Provence, France
    February 24-25, 2025

    40th World Cardiology Conference

    London, UK
    May 26-27, 2025

    6th European Summit on Cardiology Research

    Rome, Italy

    New Heart Failure Trials Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in